name: Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma of Unknown Primary

description: A squamous cell carcinoma that is associated with human papillomavirus infection and has metastasized to the neck lymph nodes from an unknown primary anatomic site.


name: Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma of Unknown Primary

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A squamous cell carcinoma that is not associated with human papillomavirus infection and has metastasized to the neck lymph nodes from an unknown primary anatomic site.


name: BOS complex subunit ncln isoform 2 (zebrafish)

description: A BOS complex subunit ncln (zebrafish) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6NZ07-2.


name: HEY2_MOUSE Hairy/enhancer-of-split related with YRPW motif protein 2 (sprot)

description: A hairy/enhancer-of-split related with YRPW motif protein 2 that is encoded in the genome of mouse.


Verruca plana

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Slightly raised wart 2-5 mm in diameter often associated with viral infections, commonly persistent in immunodeficient individuals.


name: protein max isoform long unmodified form

description: A protein max isoform long that has not been subjected to any co- or post-translational residue modification or peptide bond cleavage.


protein max isoform long

A protein max that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P61244-1 or a 1:1 ortholog thereof.


name: protein max isoform long phosphorylated 1 (human)

description: A protein max isoform long phosphorylated 1 in human. UniProtKB:P61244-1, Ser-2/Ser-11, MOD:00046.


protein max isoform long (human)

A protein max isoform long that is encoded in the genome of human.


name: protein max isoform long phosphorylated 1

description: A protein max isoform long that has been phosphorylated at two Ser residues in the N-terminal region. Example: UniProtKB:P61244-1, Ser-2/Ser-11, MOD:00046.


protein max isoform Long (rat)

A protein max isoform long that is encoded in the genome of rat.


protein max isoform 1 (mouse)

A protein max isoform long that is encoded in the genome of mouse.


name: catechol catabolic process, ortho-cleavage

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: The chemical reactions and pathways resulting in the breakdown of catechol via the ortho-cleavage pathway, in which the catechol aromatic ring is broken between the two carbon atoms bearing hydroxyl groups.


name: CK097_HUMAN Uncharacterized protein C11orf97 (sprot)

description: An uncharacterized protein C11orf97 that is encoded in the genome of human.


NIS1_YEAST Protein NIS1 (sprot)

A protein that is a translation product of the NIS1 gene in yeast.


name: linker for activation of T-cells family member 1 isoform h3 (human)

description: A linker for activation of T-cells family member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43561-3.


name: linker for activation of T-cells family member 1

description: A protein that is a translation product of the human LAT gene or a 1:1 ortholog thereof.


name: linker for activation of T-cells family member 1 isoform h2 (human)

description: A linker for activation of T-cells family member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43561-2.


name: linker for activation of T-cells family member 1 isoform h4 (human)

description: A linker for activation of T-cells family member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43561-4.


name: linker for activation of T-cells family member 1 phosphorylated 2 (human)

description: A linker for activation of T-cells family member 1 (human) that has been post-translationally modified to include phosphotyrosine at positions 200 and 220 of the amino acid sequence represented by UniProtKB:O43561. UniProtKB:O43561, Tyr-200/Tyr-220, MOD:00048.


name: linker for activation of T-cells family member 1 isoform h5 (human)

description: A linker for activation of T-cells family member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43561-5.


name: linker for activation of T-cells family member 1 phosphorylated 1 (human)

description: A linker for activation of T-cells family member 1 (human) that has been post-translationally modified to include phosphotyrosine at positions 156, 161, 200, 220 and 255 of the amino acid sequence represented by UniProtKB:O43561. UniProtKB:O43561, Tyr-156/Tyr-161/Tyr-200/Tyr-220/Tyr-255, MOD:00048.


name: linker for activation of T-cells family member 1 isoform h1 (human)

description: A linker for activation of T-cells family member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43561-1.


name: linker for activation of T-cells family member 1 isoform h2 phosphorylated 1 (human)

description: A linker for activation of T-cells family member 1 isoform h2 (human) that has been phosphorylated on the residues at the positions equivalent to Tyr-127, Tyr-132, Tyr-171, Tyr-191, and Tyr-226 of the amino acid sequence represented by UniProtKB:O43561-2. UniProtKB:O43561-2, Tyr-127/Tyr-132/Tyr-171/Tyr-191/Tyr-226, MOD:00048.


name: BIN2_MOUSE Bridging integrator 2 (sprot)

description: A bridging integrator 2 that is encoded in the genome of mouse.


name: bridging integrator 2 cysteinylated 1 (mouse)

description: A bridging integrator 2 (mouse) that has been cysteinylated on the residue at the position equivalent to Cys-205 of the amino acid sequence represented by UniProtKB:D3Z6Q9. UniProtKB:D3Z6Q9, Cys-205, MOD:00765.


myrothenone A

An alicyclic ketone which is 3-oxocyclopent-1-ene substituted by a formamido group at position 1 as well as vinyl and hydroxy groups at position 4. It is isolated from a marine derived fungus Myrothecium sp. and acts as an inhibitor of tyrosinase enzyme (EC 1.14.18.1).


TP53-target gene 5 protein

A protein that is a translation product of the human TP53TG5 gene or a 1:1 ortholog thereof.


name: TP53-target gene 5 protein phosphorylated 1 (human)

description: A TP53-target gene 5 protein (human) that has been phosphorylated on the residue at the position equivalent to Thr-262 of the amino acid sequence represented by UniProtKB:Q9Y2B4. UniProtKB:Q9Y2B4, Thr-262, MOD:00047.


name: T53G5_HUMAN TP53-target gene 5 protein (sprot)

description: A TP53-target gene 5 protein that is encoded in the genome of human.


Hypoplastic iris stroma

description: Underdevelopment of the stroma of iris.


name: transmembrane protease serine 13 isoform h1 (human)

description: A transmembrane protease serine 13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BYE2-1.


name: serum paraoxonase/arylesterase 1 isoform 1 (rat)

description: A serum paraoxonase/arylesterase 1 isoform 1 that is encoded in the genome of rat.


name: serum paraoxonase/arylesterase 1 isoform 1

description: A serum paraoxonase/arylesterase 1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P27169-1 or a 1:1 ortholog thereof.


name: serum paraoxonase/arylesterase 1 isoform 1 (mouse)

description: A serum paraoxonase/arylesterase 1 isoform 1 that is encoded in the genome of mouse.


name: serum paraoxonase/arylesterase 1 isoform 1 (human)

description: A serum paraoxonase/arylesterase 1 isoform 1 that is encoded in the genome of human.


An oligosaccharide derivative consisting of two alpha-D-galacturonosyl-(1->3)-alpha-D-galacturonosyloxy disaccharide units linked via a dithiodiethyl divalent group. One of a panel of synthetic oligosaccharide derivatives designed to reveal a critical role of the rare aminosugar 2-acetamido-4-amino-2,4-dideoxy-D-fucose (2-acetamido-4-amino-2,4,6-trideoxy-D-galactose; D-AAT) for serotype 1 immune recognition (PMID:29632881).


name: diphthamide biosynthesis protein 3 isoform 1 (human)

description: A DPH3 isoform 1 that is encoded in the genome of human.


CLC_DROME Clathrin light chain (sprot)

A clathrin light chain B that is encoded in the genome of fruit fly.


dADP catabolic process

description: The chemical reactions and pathways resulting in the breakdown of dADP, deoxyadenosine diphosphate (2'-deoxyadenosine 5'-diphosphate).


name: YEHX_ECOLI Glycine betaine uptake system ATP-binding protein YehX (sprot)

description: A glycine betaine uptake system ATP-binding protein YehX that is encoded in the genome of Escherichia coli K-12.


name: actin filament-associated protein 1-like 2 isoform m1 (mouse)

description: An actin filament-associated protein 1-like 2 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5DTU0-1.


name: AF1L2_MOUSE Actin filament-associated protein 1-like 2 (sprot)

description: An actin filament-associated protein 1-like 2 that is encoded in the genome of mouse.


name: actin filament-associated protein 1-like 2 isoform m2 (mouse)

description: An actin filament-associated protein 1-like 2 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5DTU0-2.


name: U6 snRNA-associated Sm-like protein LSm8, initiator methionine removed form

description: A U6 snRNA-associated Sm-like protein LSm8 that has had the initiator methionine removed.


name: U6 snRNA-associated Sm-like protein LSm8, initiator methionine removed form (human)

description: A U6 snRNA-associated Sm-like protein LSm8 (human) that has had the initiator methionine removed. UniProtKB:O95777, 2-96.


erlin-1 isoform 1 (mouse)

An erlin-1 isoform 1 that is encoded in the genome of mouse.


jaspamide O

A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.


A hydroperoxyicosatrienoic acid that is (8Z,11Z,14Z)-icosatrienoic acid in which the hydroperoxy substituent is located at position 10.


icosanoid

Any member of the group of signalling molecules arising from oxidation of the three C20 essential fatty acids (EFAs) icosapentaenoic acid (EPA), arachidonic acid (AA) and dihomo-gamma-linolenic acid (DGLA).


A HETE that is (5Z,8Z,12E,14Z)-icosa-5,8,12,14-tetraenoic acid substituted at position 11 by a hydroxy group.


leukotriene E3

A leukotriene that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond.


A hydroperoxy(hydroxy)icosatetraenoic acid that is (7E,9E,11Z,13E)-icosatetraenoic acid carrying 2 hydroxy substituents at positions 5S and 6R as well as a hydroperoxy substituent at position 15S.


18-hydroxythromboxane A2

A thromboxane A that is thromboxane A2 carrying an additional hydroxy substituent at position 18.


trans-2-icosenoic acid

An icosenoic acid in which the double bond is at the 2-3 position and has E configuration.


prostaglandin D2 1-glyceryl ester

A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin D2 with the 1-hydroxy group of glycerol.


An 11-HETE in which the chiral centre at position 11 has R-configuration.


Ab 8,15-DiHETE that is derived from (5Z,9E,11Z,13E)-icosatetraenoic acid and has (8S,15S)-stereochemistry.


A hydroperoxy fatty acid that is (14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoic acid in which the hydroperoxy group is located at position 5S.


An EpETE obtained by formal epoxidation of the 17,18-double bond of all-cis-5,8,11,14,17-icosapentaenoic acid.


A bis(hydroperoxy)icosatetraenoic acid that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the two hydroperoxy groups are located at positions 5S and 15S.


6-trans-leukotriene B4

A leukotriene that is the 6-trans-isomer of leukotriene B4.


An epoxy(hydroxy)icosatrienoic acid that is the (8S,9S)-epoxy-(10R)-hydroxy derivative of icosa-(5Z,11Z,14Z)-trienoic acid.


An icosanoid that is (5Z,9E,11Z,13E)-icosatetraenoic acid carrying two hydroperoxy substituents at positions 8 and 15 (the 8S,15S-stereoisomer).


name: 17-phenoxy trinor Prostaglandin F2alpha isopropyl ester


A DHET obtained by formal dihydroxylation across the 8,9-double bond of arachidonic acid.


prostaglandin E2 2-glyceryl ester

A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin E2 with the 2-hydroxy group of glycerol.


A (5Z,8Z,11Z)-14,15-dihydroxyicosatrienoic acid in which the two stereocentres at positions 14 and 15 both have R-configuration.


15-oxoprostaglandin F2alpha

A prostaglandin Falpha obtained by formal oxidation of the 15-hydroxy group of prostaglandin F2alpha.


tafluprost

A prostaglandin Falpha that is prostaglandin F2alpha in which the carboxylic acid function has been converted to the corresponding isopropyl ester and the 3-hydroxy-1-octenyl side-chain is substituted by 3,3-difluoro-4-phenoxybut-1-enyl. Used for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.


An HETE having a 9-hydroxy group and (5E)-, (7Z)-, (11Z)- and (14Z)-double bonds.


20,20-dihydroxyleukotriene B4

A leukotriene that is leukotriene B4 in which two of the methyl hydrogens at position 20 have been replaced by hydroxy groups.


leukotriene E4 methyl ester

The methyl ester of leukotriene E4, the esterified acid group being the one forming position 1 of the icosatetraenyl chain. Leukotriene E4 methyl ester is a more lipid-soluble form of leukotriene E4.


A leukotriene that is the 11-trans-isomer of leukotriene E4.


prostaglandin G2 2-glyceryl ester

A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin G2 with the 2-hydroxy group of glycerol.


name: Prostaglandin E2 p-benzamidophenyl ester


An icosanoid that is (6E,8Z,10E,14Z)-icosatetraenoic acid substituted at positions 5 and 12 by oxo and hydroxy groups respectively.


name: 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1alpha


leukotriene B5

A leukotriene composed of (6Z,8E,10E,14Z,17Z)-icosapentaenoic acid carrying (5S)- and (12R)-hydroxy substituents.


2,3,4,5-tetranor-thromboxane B1

A monocarboxylic acid that is thromboxane B1 which is lacking four methylenes in the carboxyalkyl chain. It is a urinary metabolite of thromboxane B2.


An epoxy(hydroxy)icosatrienoic acid that is (8Z,11Z,14Z)-icosatrienoic acid having the epoxide group across positions 5-6 and the hydroxy substituent located at position 20.


A trihydroxyicosatrienoic acid that is (5Z,8Z,13E)-icosatrienoic acid in which the three hydroxy groups are located at positions 11, 12 and 15.


unoprostone isopropyl

The isopropyl ester of unoprostone.


A prostanoid that is 18,19,20-trinor-prostaglandin D2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group.


12-oxo-20-hydroxyleukotriene B4

A member of the class of leukotrienes that is leukotriene B4 in which the hydroxy group at position 12 has been oxidised to the corresponding ketone and one of the methyl hydrogens at position 20 replaced by a hydroxy group.


An 11,12-EET in which the epoxy moiety has 11R,12S-configuration.


6-epi-lipoxin A4

A C20 hydroxy fatty acid having (5S)-, (6S)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.


A prostaglandin Falpha obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin F2alpha.


2,3,4,5-tetranor-prostaglandin FM

A prostanoid that is prostaglandin E2-UM in which the oxo group at position 9 has been reduced to the corresponding alcohol (alpha-configuration).


A prostanoid-LPC that is the ammonium betaine of a 2-(prostaglandin H2)-sn-glycero-3-phosphocholine arising from deprotonation of the phosphate OH group; major species at pH 7.3.


prostaglandin F2beta

A prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is the 9beta-hydroxy epimer of prostaglandin F2alpha.


A trienoic fatty acid consisting of (8Z,11Z,14Z)-icosa-8,11,14-trienoic acid having additional (7R)-hydroxy- and (5S,6S)-epoxy groups.


latanoprost (isopropyl ester)

A prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension.


aspirin triggered lipoxin A4

A C20 hydroxy polyunsaturated fatty acid having (5S)-, (6R)- and (15R)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.


An epoxy(hydroxy)icosatrienoic acid that is (5Z,8Z,14Z)-icosatrienoic acid having the epoxide group across positions 11-12 and the hydroxy substituent located at position 20.


A member of the class of prostaglandins Falpha that is 15-oxo-prostaglandin F2alpha in which the methyl group has been oxidised to the corresponding carboxylic acid and in which the double bond at positions 13-14 has been reduced to a single bond.


nonclassic icosanoid

Any biologically active signalling molecule made by oxygenation of C20 fatty acids other than the classic icosanoids (the leukotrienes and the prostanoids).


leukotriene C4 methyl ester

The methyl ester of leukotriene C4, the esterified acid group being the one forming position 1 of the icosatetraenyl chain.  Leukotriene C4 methyl ester is a more lipid-soluble form of leukotriene C4.


gadelaidic acid

An icosenoic acid having a trans- double bond at position 9.


A hydroperoxy fatty acid that is (8Z,10E,14Z)-icosatrienoic acid in which the hydroperoxy group is located at the 12(S)-position.


An epoxy(hydroxy)icosatrienoic acid consisting of (5Z,9E,14Z)-icosa-5,9,14-trienoic acid having additional (8R)-hydroxy- and (11S,12S)-epoxy groups.


DHET

An icosanoid obtained by formal dihydroxylation across one of the double bonds of arachidonic acid.


A leukotriene that is 10,11-dihydroleukotriene B4 in which two of the methyl hydrogens at position 20 have been replaced by hydroxy groups.


A 9-HPETE in which the 9-hydroxy group has S stereochemistry.


19-hydroxyprostaglandin I2

A prostaglandin I that consists of prostaglandin I1 carrying an additional hydroxy substituent at position 19.


(Z)-icos-13-enoic acid

An icosenoic acid having a cis- double bond at position 13.


eoxin

Oxylipins that derive from eicosanoids.


An epoxy(hydroxy)icosatrienoic acid that is (5Z,8Z,12E)-icosatrienoic acid having the epoxide group across positions 14-15 and the hydroxy substituent located at position 11.


prostaglandin B3

A member of the class of prostaglandins A that is prosta-5,8(12),13,17-tetraen-1-oic acid carrying oxo and hydsroxy substituents at positions 9 and 15 respectively (the 5Z,13E,15S,17Z-stereoisomer).


name: 16-phenyl tetranor Prostaglandin F2alpha


12-epi LTB4

A leukotriene that is the 12S-isomer of leukotriene B4.


A hydroperoxy(hydroxy)icosatetraenoic acid that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the hydroxy and hydroperoxy substituents are located at positions 5S and 15S respectively.


An EET obtained by formal epoxidation of the 14,15-double bond of arachidonic acid.


prostaglandin F2alpha 2-glyceryl ester

A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin F2alpha with the 2-hydroxy group of glycerol.


A HPETE in which the hydroxy group is located at position 9 with the four double bonds at positions 5, 7, 11 and 14 (the 5Z,7E,11Z,14Z geoisomer).


prostaglandin D3

A member of the class of prostaglandins D that is prosta-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,13E,15S,17Z-stereoisomer).


A HPETE that consists of (5Z,8Z,11Z,13E)-icosatetraenoic acid in which the hydroperoxy group is located at position 15.


name: (1S,2R)-3-oxo-2-pentylcyclopentane-1-octanoic acid methyl ester


An icosanoid that is any icosatetraenoic acid bearing hydroxy and hydroperoxy substituents. An oxidation product of icosatetraenoic acid metabolism.


name: 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid propan-2-yl ester


5,8,11-icosatriynoic acid

A C20 polyunsaturated fatty acid having three triple bonds in the 5-, 8- and 11-positions.


A bis(hydroperoxy)icosatetraenoic acid that is (5Z,8Z,10E,12E)-icosatetraenoic acid carrying two hydroperoxy substituents at positions 14 and 15 (the 14R,15S-stereoisomer).


A HETE that is arachidonic acid carrying a hydroxy substituent at position 7.


18-carboxy-19,20-dinor-leukotriene E4

An icosanoid that is leukotriene E4 in which two methylene groups are removed from the carboxyalkyl chain attached to the non-conjugated double bond.


An 8,9-EET in which the epoxy moiety has 8S,9R-configuration.


An epoxy(hydroxy)icosatrienoic acid consisting of (5Z,9E,14Z)-icosa-5,9,14-trienoic acid having additional (8R)-hydroxy- and (11R,12R)-epoxy groups.


10,11-dihydro-12-oxoleukotriene B4

A hydroxy polyunsaturated fatty acid that is (6Z,8E,14Z)-icosatrienoic acid carrying hydroxy and oxo substituents at positions 5 and 12 respectively.


A 16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4 in which the double bond at position 13-14 has E-configuration.


A prostanoid that is 2,3-dinor-6-oxo-prostaglandin F1alpha in which a hydrogen at position 19 is replaced by a hydroxy group.


A HETE that is arachidonic acid carrying a hydroxy substituent at position 10.


name: 5-trans-17-phenyl trinor Prostaglandin F2alpha ethyl amide


A DiHETE that is (6E,8Z,12E,14Z)-icosatetraenoic acid in which the two hydroxy substituents are placed at the 5S- and 11R-positions.


2,3-dinor-6-oxoprostaglandin F1alpha

A prostanoid that is prostaglandin F1alpha lacking two methylenes in the carboxyalkyl chain and bearing an oxo group at the 6-position.


A prostanoid that is prostaglandin E2 in which both of the hydrogens at position 16 have been replaced by methyl groups. A synthetic analogue of prostaglandin E2, it is a potent inhibitor of pancreatic function and growth of experimental tumors. It also protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers.


A (5Z,8Z,11Z)-14,15-dihydroxyicosatrienoic acid in which the two stereocentres at positions 14 and 15 both have S-configuration.


A polyunsaturated fatty acid consisting of (7E,9E,11Z,14Z,16E)-icosapentaenoic acid carrying additional 18-hydroxy and (5S,6S)-epoxy groups.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl.


leukotriene F4

A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents.


19-hydroxyleukotriene B4

A leukotriene that is leukotriene B4 carrying an additional hydroxy substituent at position 19.


13,14-dihydro-15-oxo-prostaglandin E2

The 13,14-dihydro derivative of 15-oxo-prostaglandin E2.


A DiHETE that is (5Z,8Z,10E,12E)-icosatetraenoic acid carrying two hydroxy substituents at positions 14 and 15 (the 14R,15S-stereoisomer).


An EET obtained by formal epoxidation of the 8,9-double bond of arachidonic acid.


epoxy(hydroxy)icosatrienoic acid

A nonclassic icosanoid that consists of any icosatrienoic acid carrying epoxy and hydroxy substituents.


A HETE having an (8S)-hydroxy group and (5Z)-, (9E)-, (11Z)- and (14Z)-double bonds.


A 16-HETE in which the chiral centre at position 16 has S-configuration.


A hydroperoxy fatty acid that is (5Z,8Z,10E)-icosatrienoic acid in which the hydroperoxy group is located at the 12(S)-position.


An 11-HETE in which the chiral centre at position 11 has S-configuration.


A HETE that is arachidonic acid carrying a hydroxy substituent at position 13.


prostaglandin H2 2-glyceryl ester

A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin H2 with the 2-hydroxy group of glycerol.


Delta(6)-trans-12-epi-leukotriene B4

A leukotriene that is the 6-trans,12S-isomer of leukotriene B4.


A  clavulone that is a chlorinated prostanoid isolated from marine corals.


lipoxin

A nonclassic icosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.


A HPETE that consists of (6E,8Z,11Z,14Z)-icosatetraenoic acid in which the hydroperoxy group is located at position 5.


6-oxoprostaglandin E1

A prostaglandin E that is prostaglandin E1 bearing a keto substituent at the 6-position.


A HETE having a (9S)-hydroxy group and (5Z)-, (7E)-, (11Z)- and (14Z)-double bonds.


A DiHETE that is 5-HETE carrying an additional hydroxy substituent at position 20.


12-oxo-6-trans-leukotriene B4

A leukotriene consisting of 6-trans-leukotriene B4 having a 12-keto group in place of the 12-hydroxy group.


A 17(18)-EpETE in which the epoxy group has (17R,18S)-configuration.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl


A prostaglandin Falpha obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin F1alpha.


bis(hydroperoxy)icosatetraenoic acid

An icosanoid that consists of any icosatetraenoic acid carrying two hydroperoxy substituents at unspecified positions.


A hydroperoxy fatty acid that is (8Z,10E,14Z)-icosatrienoic acid in which the hydroperoxy group is located at position 12.


A leukotriene compound having double bonds in the 7-, 9-, 11- and 14-positions and 5(S)- and 6(S)-hydroxy substituents.


10,11-dihydroleukotriene B4

A leukotriene obtained by formal dehydrogenation of the 10,11-double bond in leukotriene B4.


An epoxy(hydroxy)icosatrienoic acid consisting of (5Z,8Z,11Z)-icosa-5,9,14-trienoic acid having additional (13R)-hydroxy- and (14S,15S)-epoxy groups.


An HETE having a 8-hydroxy group and (5Z)-, (9E)-, (11Z)- and (14Z)-double bonds.


An epoxy(hydroxy)icosatrienoic acid that is (5Z,11Z,14Z)-icosatrienoic acid having the epoxide group across positions 8-9 and the hydroxy substituent located at position 20.


A trihydroxyicosatrienoic acid that is (5Z,8Z,11Z)-icosatrienoic acid in which the three hydroxy groups are located at positions 13, 14 and 15.


An EpETE obtained by formal epoxidation of the 8,9-double bond of all-cis-5,8,11,14,17-icosapentaenoic acid.


20-hydroxylipoxin B4

A member of the class of lipoxins that is lipoxin B4 carrying an additional hydroxy substituent at position 20.


(R)-PGJ2-S-glutathione conjugate

A glutathione conjugate obtained by formal 1,4-addition of the thiol function of glutathione to the enone function of prostaglandin J2 (where the newly formed stereocentre at position 9 has R-configuration).


prostaglandin H1

A member of the class of prostaglandins H that is prostaglandin H2 lacking the double bond at position 5.


13,14-dihydroprostaglandin F2alpha

A prostaglandins Falpha that is prost-5-en-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15.


A HETE having a (19S)-hydroxy group and all-cis double bonds at positions 5, 8, 11 and 14.


A HETE that consists of arachidonic acid bearing an additional hydroxy substituent at position 17.


trihydroxyicosatrienoic acid

A nonclassic icosanoid that consists of any icosatrienoic acid carrying three hydroxy substituents.


A trihydroxyicosatrienoic acid that is (5Z,8Z,12E)-icosatrienoic acid in which the three hydroxy groups are located at positions 11, 14 and 15.


A leukotriene that is (5S,7E,9E,12R,14Z)-5,12-dihydroxyicosa-7,9,14-trienoic acid to which a glutathionyl group is attached at position 6 via a sulfide linkage.


N-acetylleukotriene E4

A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and an N-acetyl-L-cystein-S-yl group at position 6 (6R); it is a major bilary metabolite of cysteinyl leukotrienes.


prostaglandin F1alpha alcohol

A member of the class of prostaglandins Falpha that is prostaglandin F1alpha in which the carboxy group has been reduced to the corresponding primary alcohol.


A 5(),6(S)-epoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid in which the 18-hydroxy group has S-configuration.


Any isoprostane derived from the non-enzymatic, free radical oxidation of arachidonic acid.


carbocyclic thromboxane A2

A member of the class of thromboxanes that is thromboxane A2 in which the bridging oxygen has been replaced by a methylene group.


name: 13,14-dihydro-15-keto PGF2alpha isopropyl ester


prostaglandin I2 2-glyceryl ester

A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin I2 with the 2-hydroxy group of glycerol.


4,5-leukotriene A4

A leukotriene whose structure comprises leukotriene A4 having a (4R,5R)-epoxy group.


A hydroperoxyicosatrienoic acid that is (8Z,12E,14Z)-icosatrienoic acid in which the hydroperoxy substituent is located at position 11.


thromboxane

A class of oxygenated oxane derivatives, originally derived from prostaglandin precursors in platelets, that stimulate aggregation of platelets and constriction of blood vessels.


leukotriene D3

A leukotriene that is (5S,7E,9E,11Z)-5-hydroxyicosa-7,9,11-trienoic acid in which an L-cysteinylglycinyl group is attached at position 6R via a sulfide linkage.


The (R)-enantiomer of 8-HPETE.


(R)-PGA2-S-glutathione conjugate

A glutathione conjugate obtained by formal 1,4-addition of the thiol function of glutathione to the enone function of prostaglandin A2 (where the newly formed stereocentre at position 11 has R-configuration).


name: 17-phenyl trinor Prostaglandin F2alpha-d4


thromboxane B3

A member of the class of thromboxanes B that is (5Z,13E,17Z)-thromboxa-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15.


(11Z)-icos-11-enoic acid

An icosenoic acid having a cis- double bond at position 11.


A hydroperoxy fatty acid that is (5Z,8Z,10E,14Z,17Z)-icosapentaenoic acid in which the hydroperoxy group is located at the 12-position.


A hydroperoxyicosatrienoic acid that is (9E,11Z,14Z)-icosatrienoic acid in which the hydroperoxy substituent is located at position 8R.


A DiHETE that consists of 6E,8Z,11Z,13E-icosatetraenoic acid having the two hydroxy groups located at positions 5 and 15.


A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoic acid in which the three chiral centres at positions 13, 14 and 15 all have S-configuration.


20-hydroxyprostaglandin A1

A prostaglandin A derivative that is prostaglandin A1 in which one of the methyl hydrogens at position 20 has been replaced by a hydroxy group.


hydroperoxyicosapentaenoic acid

A hydroperoxy polyunsaturated fatty acid that is any icosapentaenoic fatty acid carrying a single hydroperoxy substituent.


EpETE

An epoxy fatty acid obtained by formal epoxidation of one of the double bonds of any icosapentaenoic acid.


2,3-dinor-prostaglandin E2

A prostanoid that is prostaglandin E2 lacking two methylenes in the carboxyalkyl chain.


A prostanoid that is 18,19,20-trinor-prostaglandin E2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group.


A HETE that consists of arachidonic acid bearing a hydroxy substituent at position 18.


hydroperoxyicosatrienoic acid

A hydroperoxy polyunsaturated fatty acid that is any icosatrienoic fatty acid carrying a single hydroperoxy substituent.


(S)-PGA2-S-glutathione conjugate

A glutathione conjugate obtained by formal 1,4-addition of the thiol function of glutathione to the enone function of prostaglandin A2 (where the newly formed stereocentre at position 11 has S-configuration).


An 8,9-EET in which the epoxy moiety has 8R,9S-configuration.


A dihydroxyicosatetraenoic acid (7E,9E,11Z,14Z)-icosatetraenoic acid in which the two hydroxy substituents are located at positions 5S and 6R.


A C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.


A DiHETE that is 8-HETE carrying an additional hydroxy substituent at position 20.


levuglandin

Seco-prostaglandins related formally to the corresponding prostaglandins by aldol condensation.


name: (1S,2R)-3-oxo-2-pentylcyclopentane-1-hexanoic acid methyl ester


A member of the class of lipoxins that is (7E,9E,11Z,13E,17Z)-icosapentaenoic acid carrying three hydroxy substituents at positions 5, 6, and 15R.


prostaglandin

Naturally occurring compounds derived from the parent C20 acid, prostanoic acid.


A 13-HETE in which the stereocentre at position 13 has S-configuration.


prostaglandin D2 2-glyceryl ester

A 2-monoglyceride resulting from the condensation of the carboxy group of prostaglandin D2 with the 2-hydroxy group of glycerol.


An icosanoid that is (6E,8Z,11Z,14Z,17Z)-icosapentaenoic acid substituted at positions 5 and 20 by hydroxy groups.


20-hydroxyprostaglandin E2

A prostaglandin E derivative that is prostaglandin E2 in which one of the methyl hydrogens at position 20 has been replaced by a hydroxy group.


19-hydroxyprostaglandin H1

A prostaglandin H that consists of prostaglandin H1 bearing an additional hydroxy substituent at position 19.


A DiHETE that is 12-HETE carrying an additional hydroxy substituent at position 20.


prostaglandin F2alpha 1-ethanolamide

An N-acylethanolamine compound formed by a condensation of prostaglandin F2alpha and ethanolamine.


17-icosenoic acid

An icosenoic acid having a double bond at position 17.


A DiHETE that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the two hydroxy substituents are placed at the 5S- and 15R-positions.


A 16-HETE in which the chiral centre at position 16 has R-configuration.


name: (1S,2S)-3-oxo-2-(2Z-pentenyl)cyclopentane-1-hexanoic acid methyl ester


A 14,15-EET in which the epoxy moiety has 14R,15S-configuration.


name: 15(S)-15-methyl Prostaglandin F2alpha ethyl amide


An 11,12-EET in which the epoxy moiety has 11S,12R-configuration.


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl.


A HPETE that is (5Z,8Z,11Z,13E,15R)-icosa-5,8,11,13-tetraenoic acid with the hydroperoxy group located at position 15 (the R-enantiomer).


EET

An icosanoid obtained by formal epoxidation of one of the double bonds of arachidonic acid.


An icosanoid that is (6E,8Z,11Z,14Z,16E)-icosa-6,8,11,14,16-pentaenoic acid substituted at positions 5S and 18 by hydroperoxy and hydroxy groups respectively.


20-hydroxyprostaglandin E1

A prostaglandin E derivative that is prostaglandin E1 in which one of the methyl hydrogens at position 20 has been replaced by a hydroxy group.


HETE

Any monohydroxylated icosanoid having four double bonds.


A 17(18)-EpETE in which the epoxy group has (17S,18R)-configuration.


20-oxoleukotriene E4

A leukotriene that is leukotriene E4 in which the terminal methyl grop has been oxidised to the corresponding aldehyde


icosenoic acid

An icosanoid comprising icosanoic acid having one C=C bond at any position.


An icosanoid that is leukotriene E3 in which the terminal octyl group is replaced by a carboxymethyl group.


name: 16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester


An icosanoid that is (6E,8Z,11Z,13E)-icosa-6,8,11,13-tetraenoic acid substituted at positions 5 and 15 by hydroperoxy and hydroxy groups respectively.


prostaglandin E2 1-glyceryl ester

A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin E2 with the 1-hydroxy group of glycerol.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl.


15-dehydroprostaglandin A1

A member of the class of prostaglandins A obtained by oxidation of the 15-hydroxy group of prostaglandin A1 to the corresponding ketone.


A HPETE in which the hydroperoxy group is located at position 8S and the four double bonds at position 5, 9, 11 and 14 (the 5Z,9E,11Z,14Z-geoisomer).


The (5Z,8Z,10E,14Z)-stereoisomer of 12-HETE.


prostanoid

The family of natural prostaglandins and prostaglandin-like compounds including prostacyclins and thromboxanes.


A prostaglandin Falpha that is prostaglandin F1alpha bearing keto substituents at positions 6 and 15.


An O-acyl carbohydrate obtained by the formal condensation of the 20-carboxy group of 20-hydroxy-20-oxoleukotriene B4 with the anomeric hydroxy group of beta-D-glucuronic acid.


An icosanoid that is leukotriene E4 in which the isolated double bond has migrated into conjugation with the triene moiety and in which four methylene groups have been lost from the resulting carboxyalkyl chain.


A 12-HPEPE in which the hydroperoxy group at positions 12 has S-configuration.


13,14-dihydrolipoxin A4

A trienoic fatty acid obtained by formal hydrogenation across the 13,14-double bond of lipoxin A4.


thromboxane B1

A thromboxane B that is thromboxane B2 in which the double bond at position 5-6 has been reduced to a single bond.


20-carboxyleukotriene E4

A leukotriene that is leukotriene E4 in which the terminal methyl grop has been oxidised to the corresponding carboxylic acid.


A HETE that consists of arachidonic acid bearing an additional hydroxy substituent at position 16.


An epoxy(hydroxy)icosatrienoic acid that is (5Z,8Z,11Z)-icosatrienoic acid having the epoxide group across positions 14-15 and the hydroxy substituent located at position 20.


An EET obtained by formal epoxidation of the 11,12-double bond of arachidonic acid.


dihydroxyicosatetraenoic acid

A hydroxy fatty acid that is any eicosatetraenoic acid bearing two hydroxy substituents.


fluprostenol

An organofluorine compound that is racemic prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of its isopropyl ester prodrug, travoprost, are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. The isopropyl ester group of travoprost is hydrolysed to the biologically active free acid by esterases in the cornea.


prostaglandin G1

A member of the class of prostaglandins G that is 9alpha,11alpha-epidioxy-13-trans-prostenoic acid carrying an additional hydroperoxy substituent at the 15S-position.


A DiHETE that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the two hydroxy substituents are placed at the 5S- and 15S-positions.


2,3-dinor-8-epi-prostaglandin F1alpha

A prostanoid that is prostaglandin F1alpha lacking two methylenes in the carboxyalkyl chain and having inverted stereochemistry at the 8-position.


An icosanoid that is (6E,8Z,11Z,13E)-icosatetraenoic acid substituted at positions 5 and 15 by oxo and hydroxy groups respectively.


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl


name: 16-phenoxy tetranor PGF2alpha cyclopropyl methyl amide


A polyunsaturated fatty acid consisting of (7E,9E,11Z,14Z,16E)-icosapentaenoic acid carrying additional (18R)-hydroxy and (5S,6S)-epoxy groups.


A (5Z,8Z,14Z)-11,12-dihydroxyicosatrienoic acid in which the two stereocentres at positions 11 and 12 both have R-configuration.


name: 8-iso-17-phenyl trinor Prostaglandin F2alpha


isoprostane

Any icosanoid with a prostaglandin-like structure formed in vivo by non-enzymatic free radical-catalysed reactions involving peroxidation of essential fatty acids (mainly arachidonic acid but also other fatty acids with 3 or more double bonds). Isoprostanes are abundant in tissues and fluids and have immunomodulating activity. Their concentration is dependent on the amount of oxidative stress and may be upregulated in certain diseases such as cancer, cardiovascular and neurological disorders.


clavulone

A class of esterified prostanoids obtained from marine corals.


prostaglandin A3

A member of the class of prostaglandins A that is prosta-5,10,13,17-tetraen-1-oic acid carrying oxo and hydroxy substituents at positions 9 and 15 respectively (the 5Z,13E,15S,17Z-stereoisomer).


A (5Z,11Z,14Z)-8,9-dihydroxyicosatrienoic acid in which the two stereocentres at positions 8 and 9 both have R-configuration.


A (5Z,11Z,14Z)-8,9-dihydroxyicosatrienoic acid in which the two stereocentres at positions 8 and 9 both have S-configuration.


A 9-HPETE in which the 9-hydroxy group has R stereochemistry.


bimatoprost (free acid form)

A member of the class of prostaglandins Falpha that is latanoprost free acid with a double bond at position 13.


leukotriene C3

A leukotriene that is (5S,7E,9E,11Z)-5-hydroxyicosa-7,9,11-trienoic acid in which a glutathionyl group is attached at position 6 via a sulfide linkage.


A hydroperoxyicosatrienoic acid that is (8Z,11Z,13E)-icosatrienoic acid in which the pro-S hydrogen at position 15 has been replaced by a hydroperoxy group.


A DHET obtained by formal dihydroxylation across the 11,12-double bond of arachidonic acid.


20-hydroxy-6-trans-leukotriene B4

A member of the class of leukotrienes that is 6-trans-leukotriene B4 bearing an additional hydroxy substituent at position 20.


nonacosanoic acid

A very long-chain fatty acid comprising of 29 carbon atoms.


An EpETE obtained by formal epoxidation of the 11,12-double bond of all-cis-5,8,11,14,17-icosapentaenoic acid.


(S)-PGJ2-S-glutathione conjugate

A glutathione conjugate obtained by formal 1,4-addition of the thiol function of glutathione to the enone function of prostaglandin J2 (where the newly formed stereocentre at position 9 has S-configuration).


A 5-hydroperoxy-15-HETE stereoisomer that has 5S,15S configuration.


18-hydroxycarbocyclic thromboxane A2

A member of the class of thromboxanes that is carbocyclic thromboxane A2 carrying an additional hydroxy substituent at position 18.


prostaglandin E2-UM

A prostanoid that is prostaglandin E2 in which the acyclic hydroxy group has been oxidised to the corresponding ketone, the methyl group has been oxidised to the corresponding carboxylic acid and the 6-carboxyhexenyl group has been oxidatively cleaved to a 2-carboxyethyl group. It is the major urinary metabolite of prostaglandin E2.


An epoxy(hydroxy)icosatrienoic acid that is (5Z,8Z,11Z)-icosatrienoic acid having the epoxide group across positions 14-15 and the hydroxy substituent located at position 13.


18-hydroxyleukotriene B4

A leukotriene that is leukotriene B4 carrying an additional hydroxy substituent at position 18.


A leukotriene that is 10,11-dihydroleukotriene B4 in which the three methyl hydrogens at position 20 have been replaced by hydroxy groups.


15-dehydro-prostaglandin D2

The 15-dehydro derivative of prostaglandin D2.


An HETE that is (5Z,7E,11Z,14Z)-icosa-5,7,11,14-tetraenoic acid in which the hydroxy group is located at position 9.


A DHET obtained by formal dihydroxylation across the 5,6-double bond of arachidonic acid.


An epoxy(hydroxy)icosatrienoic acid consisting of (5Z,8Z,14Z)-icosa-5,9,14-trienoic acid having additional (10R)-hydroxy- and (11S,12S)-epoxy groups.


hydroperoxy(epoxy)icosatrienoic acid

An icosanoid derived from hydroperoxidation and epoxidation across one of the double bonds of arachidonic acid.


A hydroperoxy fatty acid that is (14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoic acid in which the hydroperoxy group is located at position 8S.


prostaglandin H2 1-ethanolamide

An N-acylethanolamine compound formed by a condensation of prostaglandin H2 and ethanolamine.


prostaglandin F3alpha

A prostaglandin Falpha that is prosta-5,13,17-trien-1-oic acid carrying three hydroxy substituents at positions 9alpha, 11alpha and 15.


name: (1S,2R)-3-oxo-2-(2Z-pentenyl)cyclopentane-1-octanoic acid methyl ester


name: 7-[(1R,2R,3R)-3-hydroxy-2-(4-hydroxy-4-methyloct-1-enyl)-5-oxocyclopentyl]heptanoic acid methyl ester


8-epi-prostaglandin E2

A prostanoid that is prostaglandin E2 having inverted stereochemistry at the 8-position.


PROSTAGLANDIN B1

A member of the class of prostaglandins B that is prosta-8(12),13-dien-1-oic acid carrying oxo and hydroxy substituents at positions 9 and 15 respectively (the 13E,15S-stereoisomer).


A HETE having an (8R)-hydroxy group and (5Z)-, (9E)-, (11Z)- and (14Z)-double bonds.


A hydroperoxy fatty acid that is (14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid in which the hydroperoxy group is located at position 12S.


A prostanoid that is prostaglandin F2alpha  which is lacking two methylenes in the carboxyalkyl chain and in which the hydroxy group at position 15 has been oxidised to the corresponding ketone.


An EpETE obtained by formal epoxidation of the 14,15-double bond of all-cis-5,8,11,14,17-icosapentaenoic acid.


15-epi-lipoxin B4

A C20 hydroxy fatty acid having (5S)-, (14R)- and (15R)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.


A 2-monoglyceride resulting from the condensation of the carboxy group of 15-deoxy-Delta(12,14)-prostaglandin J2 with the  hydroxy group at position 2 of glycerol.


20,20,20-trihydroxyleukotriene B4

A leukotriene that is leukotriene B4 in which the three methyl hydrogens at position 20 have been replaced by hydroxy groups.


prostaglandin G3

A member of the class of prostaglandins G that is 9,11-epidioxyprosta-5,13,17-trienoic acid carrying an additional hydroperoxy substituent at the 15S-position.


19-hydroxycarbocyclic thromboxane A2

A member of the class of thromboxanes that is carbocyclic thromboxane A2 carrying an additional hydroxy substituent at position 19.


name: (1S,2S)-3-oxo-2-(2Z-pentenyl)cyclopentane-1-octanoic acid methyl ester


leukotriene

Any icosanoid from that family of C20 polyunsaturated fatty acids and their derivatives generated by leukocytes from arachidonic acid, each member having four double bonds of which three are conjugated.


8-epi-prostaglandin F2alpha

An isoprostane that is prostaglandin F2alpha having inverted stereochemistry at the 8-position.


An 18-HETE in which the 18-hydroxy group has R-configuration.


A 14,15-EET in which the epoxy moiety has 14S,15R-configuration.


latanoprost (free acid form)

A prostaglandin Falpha that is an analogue of prostaglandin F2alpha in which the pentyl group has been replaced by 2-phenylethyl and where the the 13,14-double bond has undergone formal hydrogenation. Its isopropyl ester prodrug, latanoprost, is used in the treatment of open-angle glaucoma and ocular hypertension.


A leukotriene with formula C23H39NO6S that results from the metabilism of leukotriene B4 by human keratinocytes.


HPETE

Mono-hydroperoxy (e)icosatetraenoic acids (HPETEs) are the primary products of lipoxygenase-catalysed oxygenation of arachidonic acid.


A member of the class of resolvins that is (6Z,8E,10E,14Z,16E)-icosapentaenoic acid carrying three hydroxy substituents at positions 5, 12, and 18R.


15-ketoprostaglandin F1alpha

A prostaglandin Falpha that is prostaglandin F1alpha bearing a keto substituent at the 15-position. It is the initial metabolite of prostaglandin F1alpha via 15-hydroxyprostaglandin dehydrogenase.


(17Z)-icosenoic acid

A 17-icosenoic acid in which the double bond adopts cis-configuration.


prostaglandin F2alpha 1-glyceryl ester

A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin F2alpha with the 1-hydroxy group of glycerol.


A DiHETE consisting of arachidonic acid having the two hydroxy substituents located at position 17 and 18.


19-hydroxythromboxane A2

A thromboxane A that is thromboxane A2 carrying an additional hydroxy substituent at position 19.


An icosanoid that is any icosapentaenoic acid bearing hydroxy and hydroperoxy substituents. An oxidation product of icosapentaenoic acid metabolism.


An icosanoid that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond and four methylene groups have been lost from the resulting carboxyalkyl chain.


name: (1S,2S)-3-oxo-2-pentylcyclopentane-1-octanoic acid methyl ester


name: 17-phenyl trinor-13,14-dihydro Prostaglandin A2


A DHET obtained by formal dihydroxylation across the 14,15-double bond of arachidonic acid.


13,14-dihydro-15-oxoprostaglandin E1

A prostaglandin E obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin E1.


gadoleic acid

An icosenoic acid having a cis- double bond at position 9.


A leukotriene composed of (6E,8Z,10E,14Z)-icosatetraenoic acid having 5S- and 12R-hydroxy substituents.


travoprost

The isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol.


An EpETE that is (5Z,9Z,11Z,14Z)-icosatetraenoic acid in which the epoxide function is located across positions 8 and 9.


name: (1S,2S)-3-oxo-2-pentylcyclopentane-1-hexanoic acid methyl ester


11,12-dihydro-12-oxoleukotriene C4

A leukotriene  that is (5S,7E,9E,14Z)-5-hydroxy-12-oxoicosa-7,9,14-trienoic acid to which a glutathionyl group is attached at position 6 via a sulfide linkage.


A HETE that is (5Z,8Z,11Z,13E)-15-hydroxyicosa-5,8,11,13-tetraenoic acid bearing a hydroxy substituent at position 15.


A (5Z,8Z,14Z)-11,12-dihydroxyicosatrienoic acid in which the two stereocentres at positions 11 and 12 both have S-configuration.


A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoic acid in which the chiral centres at positions 14 and 15 have R- and S-configuration respectively while that at position 13 remains unspecified.


name: (1S,2R)-3-oxo-2-(2Z-pentenyl)cyclopentane-1-hexanoic acid methyl ester


name: negative elongation factor B isoform m2 (mouse)

description: A negative elongation factor B (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8C4Y3-3.


name: UBC22_ARATH Ubiquitin-conjugating enzyme E2 22 (sprot)

description: A ubiquitin-conjugating enzyme E2 S that is encoded in the genome of Arabidopsis thaliana.


Brown-Vialetto-van Laere syndrome 1

description: Any Brown-Vialetto-van Laere syndrome in which the cause of the disease is a mutation in the SLC52A3 gene.


name: EPHA6_MOUSE Ephrin type-A receptor 6 (sprot)

description: An ephrin type-A receptor 6 that is encoded in the genome of mouse.


name: ephrin type-A receptor 6 isoform 1 (mouse)

description: An ephrin type-A receptor 6 isoform 1 that is encoded in the genome of mouse.


name: protein DBF4 homolog A isoform m1 (mouse)

description: A protein DBF4 homolog A (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9QZ41-1.


BNPS-skatole

A bromoindole that is 3H-indole in which the hydrogen at position 2 has been replaced by an (o-nitrophenyl)sulfanyl group and in which the hydrogens at position 3 have been replaced by a bromine and a methyl group. It is used particularly for the selective cleavage of tryptophanyl peptide bonds (cleavage occurs at peptide bonds after amino acids with available C(gamma)=C(delta) double bonds such as tryptophan, tyrosine, and histidine).


name: pro-cathepsin H glutathionylated 1 (human)

description: A pro-cathepsin H (human) that has been glutathionylated on the residue at the position equivalent to Cys-9 of the amino acid sequence represented by UniProtKB:P09668. UniProtKB:P09668, Cys-9, MOD:00234.


intravascular fasciitis

description: A rare self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the vessels. It is characterized by the presence of plump spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity.


name: ILVC_BRUSI Ketol-acid reductoisomerase (NADP(+)) (sprot)

description: A ketol-acid reductoisomerase (NADP(+)) that is encoded in the genome of Brucella suis ATCC 23445.


MRG/MORF4L-binding protein

A protein that is a translation product of the human MRGBP gene or a 1:1 ortholog thereof.


name: MRG/MORF4L-binding protein isoform m1 (mouse)

description: An MRG/MORF4L-binding protein (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9DAT2-1.


name: Q7K003_DROME MRG/MORF4L binding protein (trembl)

description: An MRG/MORF4L-binding protein that is encoded in the genome of fruit fly.


name: MRGBP_MOUSE MRG/MORF4L-binding protein (sprot)

description: An MRG/MORF4L-binding protein that is encoded in the genome of mouse.


name: MRG/MORF4L-binding protein isoform m2 (mouse)

description: An MRG/MORF4L-binding protein (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9DAT2-2.


name: MRGBP_HUMAN MRG/MORF4L-binding protein (sprot)

description: An MRG/MORF4L-binding protein that is encoded in the genome of human.


name: Q9FZD2_ARATH Chromatin modification-like protein (trembl)

description: An MRG/MORF4L-binding protein that is encoded in the genome of Arabidopsis thaliana.


name: GLGB2_ARATH 1,4-alpha-glucan-branching enzyme 2-2, chloroplastic/amyloplastic (sprot)

description: A protein that is a translation product of the SBE2.2 gene in Arabidopsis thaliana.


name: Sin3 histone deacetylase corepressor complex component SDS3, initiator methionine removed form (human)

description: A Sin3 histone deacetylase corepressor complex component SDS3 (human) that has had the initiator methionine removed. UniProtKB:Q9H7L9, 2-328.


name: Sin3 histone deacetylase corepressor complex component SDS3, initiator methionine removed ubiquitinated form (human)

description: A Sin3 histone deacetylase corepressor complex component SDS3 (human) that has had the initiator methionine removed and that includes at least one ubiquitinated lysine. UniProtKB:Q9H7L9, 2-328, MOD:01148.


name: prolyl endopeptidase-like isoform r1 (rat)

description: A prolyl endopeptidase-like (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5HZA6-1.


name: Stage IV Major Salivary Gland Carcinoma with Metastasis

description: Stage IV carcinoma of the major salivary glands with regional lymph nodes and/or distant metastases.


teneurin-3 isoform mA2B1 (mouse)

A teneurin-3 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9WTS6-5.


name: dual specificity protein phosphatase 13B isoform h5 (human)

description: A dual specificity protein phosphatase 13B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UII6-5.


Cervical Micropapillary Adenocarcinoma

description: A rare, invasive adenocarcinoma that arises from the cervix and is characterized by a micropapillary architecture.


calcitriol 25-O-(beta-D-glucuronide)

A steroid glucosiduronic acid that is calcitriol in which the hydroxy hydrogen at position 25 has been replaced by a beta-D-glucuronyl residue.


uromodulin N-glycosylated 357 (human)

A uromodulin (human) that has been N-glycosylated at the residue equivalent to Asn-76 of the amino acid sequence represented by UniProtKB:P07911-1, in which the glycan structure is represented by GlyTouCan:G79565XA. Example: UniProtKB:P07911-1, Asn-76, MOD:00160~GNO:G79565XA.


name: cleavage between 5.8S rRNA and 2S rRNA of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA)

description: Endonucleolytic cleavage between the 5.8S rRNA and the 2S rRNA of an rRNA molecule originally produced as a tetracistronic rRNA transcript that contained the Small SubUnit (SSU) rRNA, the 5.8S rRNA, 2S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript.


name: endonucleolytic cleavage of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA)

description: Endonucleolytic cleavage of a pre-rRNA molecule originally produced as a tetracistronic rRNA transcript that contains the Small SubUnit (SSU) rRNA, the 5.8S rRNA, 2S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript. Primary ribosomal RNA transcripts with four genes, in this order, are produced in the nuclei of D. melanogaster as well as in those of other dipteran species.


name: cleavage between SSU-rRNA and 5.8S rRNA of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA)

description: Endonucleolytic cleavage between the SSU-rRNA and the 5.8S rRNA of an rRNA molecule originally produced as a tetracistronic rRNA transcript that contained the Small SubUnit (SSU) rRNA, the 5.8S rRNA, 2S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript.


name: cleavage between 2S rRNA and LSU-rRNA of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA)

description: Endonucleolytic cleavage between the LSU-rRNA and the 2S rRNA of an rRNA molecule originally produced as a tetracistronic rRNA transcript that contained the Small SubUnit (SSU) rRNA, the 5.8S rRNA, 2S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript.


An organic sulfide that consists of two 4-hydroxybenzyl groups covalently bound to a central sulfur atom. It is isolated from Gastrodia elata and Pleuropterus ciliinervis and exhibits neoroprotective activity.


name: laminin subunit beta-1 methylated 1 (human)

description: A laminin subunit beta-1 (human) that has been methylated on the residue at the position equivalent to Cys-1009 of the amino acid sequence represented by UniProtKB:P07942. UniProtKB:P07942, Cys-1009, MOD:00660.


name: ETS translocation variant 4 isoform m2 (mouse)

description: An ETS translocation variant 4 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P28322-2.


name: TPIS_CHICK Triosephosphate isomerase (sprot)

description: A triosephosphate isomerase that is encoded in the genome of chicken.


name: torsin-1A-interacting protein 1 isoform h3 (human)

description: A torsin-1A-interacting protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5JTV8-3.


chaperedoxin

A protein that is a translation product of the Escherichia coli K-12 ybbN gene or a 1:1 ortholog thereof.


CNOX_ECOLI Chaperedoxin (sprot)

A chaperedoxin that is encoded in the genome of Escherichia coli K-12.


name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IVB includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.)


name: Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage

description: A term that refers to the pathologic staging of gastroesophageal junction adenocarcinoma according to the American Joint Committee on Cancer, 8th edition.


name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IIIB includes: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IA includes: (T1a, N0, M0, G1); (T1a, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)


name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IIIA includes: (T1, N2, M0, Any G); (T2, N1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage 0 includes: Tis, N0, M0, GN/A. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)


name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IIA includes: (T2, N0, M0, G3); (T2, N0, M0, GX). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)


name: Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage I includes: IA: (T1a, N0, M0, G1); (T1a, N0, M0, GX); IB: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX); IC: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)


name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage II includes: IIA: (T2, N0, M0, G3); (T2, N0, M0, GX); IIB: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T2: Tumor invades the muscularis propria. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)


name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage III includes: IIIA: (T1, N2, M0, Any G); (T2, N1, M0, Any G); IIIB: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IC includes: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)


name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IVA includes: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IIB includes: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IV includes: IVA: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G); IVB: (Any T, Any N, M1, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)


name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IB includes: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. (AJCC 8th ed.)


name: YDCZ_ECOLI Inner membrane protein YdcZ (sprot)

description: An inner membrane protein YdcZ that is encoded in the genome of Escherichia coli K-12.


name: Refractory High Grade Burkitt-Like Lymphoma

description: High grade B-cell lymphoma Burkitt-like lymphoma resistant to treatment.


name: Recurrent High Grade Burkitt-Like Lymphoma

description: The reemergence of high grade B-cell lymphoma Burkitt-like lymphoma after a period of remission.


name: Stage II High Grade Adult Non-Hodgkin's Lymphoma


name: Stage II High Grade Burkitt-Like Lymphoma

description: Stage II NHL means involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ)


name: High Grade B-Cell Non-Hodgkin's Lymphoma


name: Stage I High Grade Burkitt-Like Lymphoma

description: Stage I NHL means involvement of a single lymph node region (I) or localized involvement of a single extralymphatic organ or site (IE). (from PDQ)


name: Recurrent High Grade Adult Non-Hodgkin's Lymphoma


name: Stage IV High Grade Adult Non-Hodgkin's Lymphoma


name: Stage IV High Grade Burkitt-Like Lymphoma

description: Stage IV NHL means disseminated (multifocal) involvement of one or more extralymphatic sites with or without associated lymph node involvement or isolated extralymphatic organ involvement with distant (nonregional) nodal involvement. (from PDQ)


name: Stage III High Grade Adult Non-Hodgkin's Lymphoma


name: Stage I High Grade Adult Non-Hodgkin's Lymphoma


name: Stage III High Grade Burkitt-Like Lymphoma

description: Stage III NHL means involvement of lymph node regions on both sides of the diaphragm (III) that may also be accompanied by localized involvement of an extralymphatic organ or site (IIIE), by involvement of the spleen (IIIS), or both (IIIS+E). (from PDQ)


High Grade Burkitt-Like Lymphoma

description: A high grade B-cell lymphoma showing greater pleomorphism in nuclear size and shape than the classical Burkitt lymphoma.


allocholic acid

An allo-bile acid that is 5alpha-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12.


name: Muellerian-inhibiting factor isoform 1 cleaved and glycosylated form

description: A Muellerian-inhibiting factor isoform 1 cleaved 1 that includes at least one glycosylated residue.


name: Muellerian-inhibiting factor isoform 1 cleaved and glycosylated 2

description: A Muellerian-inhibiting factor isoform 1 cleaved and glycosylated form that has been cleaved at the RxxR dibasic cleavage site rendering the propeptide and the mature protein non-covalently bound.


name: Muellerian-inhibiting factor isoform 1 cleaved and N-glycosylated 2 (human)

description: A Muellerian-inhibiting factor isoform 1 cleaved and glycosylated 2 in human, in which the cleaved parts remain joined by disulfide bonds. The position(s) of glycosylation sites have not been experimentally determined. UniProtKB:P03971-1, 26-450, 451-560, MOD:00160.


name: NLTP1_ARATH Non-specific lipid-transfer protein 1 (sprot)

description: A protein that is a translation product of the LTP1 gene in Arabidopsis thaliana.


name: FCERA_MOUSE High affinity immunoglobulin epsilon receptor subunit alpha (sprot)

description: A high affinity immunoglobulin epsilon receptor subunit alpha that is encoded in the genome of mouse.


name: NU116_YEAST Nucleoporin NUP116/NSP116 (sprot)

description: A protein that is a translation product of the NUP116 gene in yeast.


name: CAT1_SCHPO Cationic amino acid transporter 1 (sprot)

description: A protein that is a translation product of the cat1 gene in Schizosaccharomyces pombe 972h-.


name: Stage IVB Esophageal Squamous Cell Carcinoma


name: sodium/nucleoside cotransporter 1 isoform h2 (human)

description: A sodium/nucleoside cotransporter 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O00337-2.


name: lactotransferrin, signal peptide removed form (human)

description: A lactotransferrin (human) that has had the signal peptide removed. UniProtKB:P02788, 20-710.


lymphangioleiomyomatosis

description: A multifocal neoplasm with perivascular epithelioid cell differentiation affecting almost exclusively females of child-bearing age. It is characterized by the presence of smooth muscle and epithelioid cells and by the proliferation of lymphatic vessels. Sites of involvement include the lungs, mediastinum, and the retroperitoneum. It usually presents with chylous pleural effusion or ascites.


chronic sphenoidal sinusitis

description: Inflammation of the sphenoid sinus that typically lasts beyond eight weeks. It is caused by infections, allergies, and the presence of sinus polyps or a deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties.


name: band 4.1-like protein 3 isoform m3 (mouse)

description: A band 4.1-like protein 3 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9WV92-3.


name: 1alpha,25-dihydroxy-2beta-(2-hydroxyethoxy)vitamin D3 / 1alpha,25-dihydroxy-2beta-(2-hydroxyethoxy)cholecalciferol


cuticle collagen 6 isoform a (worm)

A cuticle collagen 6 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P18831-1.


name: serine/threonine-protein kinase Kist methylated 2 (human)

description: A serine/threonine-protein kinase Kist (human) that has been methylated on the residue at the position equivalent to Cys-207 of the amino acid sequence represented by UniProtKB:Q8TAS1-1. Example: UniProtKB:Q8TAS1-1, Cys-207, MOD:00660.


name: N-[6-[2-[(6-methoxy-2-quinolinyl)methylidene]hydrazinyl]-6-oxohexyl]carbamic acid tert-butyl ester


A phytocannabinoid that is Delta(9)-tetrahydrocannabinol in which the C-11 methyl has been fully oxidised to a carboxy group. Further enzymatic oxidation product of 11-hydroxy-Delta(9)-tetrahydrocannabinol.


name: ATP-dependent RNA helicase DHX15 isoform 1 (human)

description: An ATP-dependent RNA helicase DHX15 isoform 1 that is encoded in the genome of human.


protein DPCD isoform r2 (rat)

A protein DPCD (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6AYM4-2.


name: short transient receptor potential channel 6 isoform h1 (human)

description: A short transient receptor potential channel 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y210-1.


name: short transient receptor potential channel 6

description: A transient receptor potential cation channel TRPC3/6/7 that is a translation product of the human TRPC6 gene or a 1:1 ortholog thereof.


name: short transient receptor potential channel 6 isoform h3 (human)

description: A short transient receptor potential channel 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y210-3.


name: short transient receptor potential channel 6 phosphorylated 1 (human)

description: A short transient receptor potential channel 6 (human) that has been phosphorylated on the residue at the position equivalent to Thr-402 of the amino acid sequence represented by UniProtKB:Q9Y210-1. Example: UniProtKB:Q9Y210-1, Thr-402, MOD:00047.


name: TRPC6_MOUSE Short transient receptor potential channel 6 (sprot)

description: A short transient receptor potential channel 6 that is encoded in the genome of mouse.


name: TRPC6_HUMAN Short transient receptor potential channel 6 (sprot)

description: A short transient receptor potential channel 6 that is encoded in the genome of human.


name: short transient receptor potential channel 6 N-glycosylated 2 (human)

description: A short transient receptor potential channel 6 (human) that has been N-glycosylated at the residue equivalent to Asn-473 of the amino acid sequence represented by UniProtKB:Q9Y210-1, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:Q9Y210-1, Asn-473, MOD:00160~GNO:G12580WI.


name: short transient receptor potential channel 6 N-glycosylated 1 (human)

description: A short transient receptor potential channel 6 (human) that has been N-glycosylated at the residue equivalent to Asn-473 of the amino acid sequence represented by UniProtKB:Q9Y210-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:Q9Y210-1, Asn-473, MOD:00160~GNO:G08293MJ.


name: short transient receptor potential channel 6 isoform h2 (human)

description: A short transient receptor potential channel 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y210-2.


Benign Nasolacrimal Duct Neoplasm

description: A neoplasm that arises from the lacrimal duct and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.


name: Hodgkin lymphoma, nodular sclerosis, cellular phase

description: A nodular sclerosis Hodgkin lymphoma characterized by the presence of lacunar cells, nodular growth, and the absence of fibrosis.


name: OR5M5_MOUSE Olfactory receptor 5M5 (sprot)

description: An olfactory receptor 5M5 that is encoded in the genome of mouse.


olfactory receptor 5M5

A protein that is a translation product of the mouse Olfr1030 gene or a 1:1 ortholog thereof.


hydrogen generation via biophotolysis

description: The production of hydrogen which results from the dissociation by light of water into molecular hydrogen and oxygen. This process is observed in cyanobacteria and microalgae.


name: HYDN_ECOLI Electron transport protein HydN (sprot)

description: An electron transport protein HydN that is encoded in the genome of Escherichia coli K-12.


electron transport protein HydN

A protein that is a translation product of the Escherichia coli K-12 hydN gene or a 1:1 ortholog thereof.


name: proenkephalin-A proteolytic cleavage product

description: A proenkephalin-A that has been processed by proteolytic cleavage.


AURANTIOOBTUSIN

A trihydroxyanthraquinone that is 1,3,7-trihydroxy-9,10-anthraquinone which is by methoxy groups at positions 2 and 8, and by a methyl group at position 6.


name: envenomation resulting in induction of edema in another organism

description: A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the swelling of soft tissues of the bitten organism as a result of excess water accumulation.


name: pre-mRNA 3' end processing protein pfs-2 isoform b (worm)

description: A pre-mRNA 3' end processing protein pfs-2 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:U4PCM1-2.


aldosterone catabolic process

description: The chemical reactions and pathways resulting in the breakdown of aldosterone, a corticosteroid hormone that is produced by the zona glomerulosa of the adrenal cortex and regulates salt (sodium and potassium) and water balance.


C21-steroid hormone catabolic process

description: The chemical reactions and pathways resulting in the breakdown of C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones.


progesterone catabolic process

description: The chemical reactions and pathways resulting in the breakdown of progesterone, a steroid hormone produced in the ovary which prepares and maintains the uterus for pregnancy. Also found in plants.


name: TNNC1_HUMAN Troponin C, slow skeletal and cardiac muscles (sprot)

description: A troponin C, slow skeletal and cardiac muscles that is encoded in the genome of human.


name: troponin C, slow skeletal and cardiac muscles isoform 1 (human)

description: A troponin C, slow skeletal and cardiac muscles isoform 1 that is encoded in the genome of human.


name: uncharacterized HTH-type transcriptional regulator YidP

description: A protein that is a translation product of the Escherichia coli K-12 yidP gene or a 1:1 ortholog thereof.


name: YIDP_ECOLI Uncharacterized HTH-type transcriptional regulator YidP (sprot)

description: An uncharacterized HTH-type transcriptional regulator YidP that is encoded in the genome of Escherichia coli K-12.


LEXA_BACSU LexA repressor (sprot)

A LexA repressor that is encoded in the genome of Bacillus subtilis subsp. subtilis str. 168.


name: CML2_ARATH Calmodulin-like protein 2 (sprot)

description: A protein that is a translation product of the CML2 gene in Arabidopsis thaliana.


DNA deamination

description: The removal of an amino group from a nucleotide base in DNA. An example is the deamination of cytosine to produce uracil.


DNA cytosine deamination

description: The removal of an amino group from a cytosine residue in DNA, forming a uracil residue.


name: ATP-binding cassette sub-family C member 12 isoform h1 (human)

description: An ATP-binding cassette sub-family C member 12 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96J65-1.


name: Unresectable Cervical Adenosquamous Carcinoma

description: Cervical adenosquamous carcinoma that is not amenable to surgical resection.


name: uncharacterized protein ZK688.5 isoform a (worm)

description: An uncharacterized protein ZK688.5 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P34675-1.


name: YO25_CAEEL Uncharacterized protein ZK688.5 (sprot)

description: A protein that is a translation product of the ZK688.5 gene in worm.


name: uncharacterized protein ZK688.5 isoform b (worm)

description: An uncharacterized protein ZK688.5 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P34675-2.


name: squamosa promoter-binding-like protein 7 isoform 2 (Arabidopsis thaliana)

description: A squamosa promoter-binding-like protein 7 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8S9G8-2.


pyripyropene L

A sesquiterpenoid that consists of a heterotetracyclic system linked to a pyridine moiety. Isolated from the fungus, Aspergillus fumigatus, it exhibits inhibitory activity against acyl-CoA:cholesterol acyltransferase 2.


name: casein kinase I isoform alpha isoform CK1A-L (chicken)

description: A casein kinase I isoform alpha isoform 2 that is encoded in the genome of chicken.


name: casein kinase I isoform alpha isoform CK1A (chicken)

description: A casein kinase I isoform alpha isoform 1 that is encoded in the genome of chicken.


name: casein kinase I isoform alpha isoform CK1A-LS (chicken)

description: A casein kinase I isoform alpha (chicken) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P67962-3.


name: negative elongation factor A, initiator methionine removed form

description: A negative elongation factor A that has had the initiator methionine removed.


smooth muscle cell apoptotic process

description: Any apoptotic process in a smooth muscle cell. Smooth muscle consists of non-striated, elongated, spindle-shaped cell found lining the digestive tract, uterus, and blood vessels.


name: vascular associated smooth muscle cell apoptotic process

description: Any apoptotic process in a vascular associated smooth muscle cell.


name: Sec1 family domain-containing protein 2 isoform 1 (human)

description: A Sec1 family domain-containing protein 2 isoform 1 that is encoded in the genome of human.


name: DHYS_HUMAN Deoxyhypusine synthase (sprot)

description: A deoxyhypusine synthase that is encoded in the genome of human.


name: deoxyhypusine synthase methylated 1 (human)

description: A deoxyhypusine synthase (human) that has been methylated on the residue at the position equivalent to Cys-275 of the amino acid sequence represented by UniProtKB:P49366-1. Example: UniProtKB:P49366-1, Cys-275, MOD:00660.


name: deoxyhypusine synthase isoform Long (human)

description: A deoxyhypusine synthase isoform 1 that is encoded in the genome of human.


name: deoxyhypusine synthase isoform Short (human)

description: A deoxyhypusine synthase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P49366-2.


name: deoxyhypusine synthase isoform h3 (human)

description: A deoxyhypusine synthase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P49366-3.


name: deoxyhypusine synthase deaminated 1 (human)

description: A deoxyhypusine synthase (human) that has been deaminated on the residue at the position equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P49366-1. Example: UniProtKB:P49366-1, Asn-294, MOD:00684.


name: negative regulation of rDNA heterochromatin formation

description: Any process that decreases the rate, frequency, or extent of ribosomal DNA heterochromatin formation.


name: negative regulation of silent mating-type cassette heterochromatin formation

description: Any process that decreases the frequency, rate, or extent of heterochromatin formation at silent mating-type cassette.


name: negative regulation of DNA methylation-dependent heterochromatin formation

description: Any process that decreases the rate, frequency, or extent of DNA methylation-dependent heterochromatin formation.


name: negative regulation of regulatory ncRNA-mediated heterochromatin formation

description: Any process that decreases the frequency, rate or extent of non-coding RNA-mediated heterochromatin formation.


name: negative regulation of heterochromatin formation

description: Any process that stops, prevents, or reduces the frequency, rate or extent of heterochromatin formation.


pyrin domain-containing protein 1

A protein that is a translation product of the human PYDC1 gene or a 1:1 ortholog thereof.


name: PYDC1_HUMAN Pyrin domain-containing protein 1 (sprot)

description: A pyrin domain-containing protein 1 that is encoded in the genome of human.


name: coiled-coil domain-containing protein 60

description: A protein that is a translation product of the human CCDC60 gene or a 1:1 ortholog thereof.


name: CCD60_HUMAN Coiled-coil domain-containing protein 60 (sprot)

description: A coiled-coil domain-containing protein 60 that is encoded in the genome of human.


name: CCD60_MOUSE Coiled-coil domain-containing protein 60 (sprot)

description: A coiled-coil domain-containing protein 60 that is encoded in the genome of mouse.


name: coiled-coil domain-containing protein 60 isoform m1 (mouse)

description: A coiled-coil domain-containing protein 60 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8C4J0-1.


name: coiled-coil domain-containing protein 60 isoform m2 (mouse)

description: A coiled-coil domain-containing protein 60 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8C4J0-2.


name: CCD60_RAT Coiled-coil domain-containing protein 60 (sprot)

description: A coiled-coil domain-containing protein 60 that is encoded in the genome of rat.


protein unc-33 isoform a (worm)

A protein unc-33 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q01630-1.


UNC33_CAEEL Protein unc-33 (sprot)

A protein that is a translation product of the unc-33 gene in worm.


protein unc-33 isoform c (worm)

A protein unc-33 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q01630-3.


protein unc-33 isoform b (worm)

A protein unc-33 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q01630-2.


polidocanol

A hydroxypolyether that is nonaethylene glycol in which one of the terminal hydroxy functions is substituted by a lauryl (dodecyl) group.


name: splicing factor 3B subunit 3 isoform h3 (human)

description: A splicing factor 3B subunit 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15393-3.


name: E3 ubiquitin-protein ligase MBR1 isoform 1 (Arabidopsis thaliana)

description: An E3 ubiquitin-protein ligase MBR1 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ZQF9-1.


A polymer composed of repeating 2-[(E)-2-(3-ethenylphenyl)ethenyl]-1,4-bis(octyloxy)benzene units.


name: cyclin-dependent kinase 2-interacting protein isoform m2 (mouse)

description: A cyclin-dependent kinase 2-interacting protein (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9D0V8-2.


Vesicovaginal fistula

description: The presence of a fistula connecting the urinary bladder to the vagina.


Urogenital fistula

description: The presence of a fistula affecting the genitourinary system.


Vaginal fistula

description: The presence of a fistula of the vagina.


Rectovaginal fistula

description: The presence of a fistula between the vagina and the rectum.


Rectal fistula

description: The presence of a fistula affecting the rectum.


Bladder fistula

description: The presence of a fistula connecting the urinary bladder to another organ or the skin. The fistula can involve the bowel, the vagina, or rarely, the skin.


Urethral fistula

description: The presence of an abnormal connection between the urethra and another organ or the skin.


A sialodiosylceramide that consists of an alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc moiety attached via a glycosidic bond at position 1 of N-acylicosasphingosine.


name: DBIRD complex subunit ZNF326 isoform h3 (human)

description: A DBIRD complex subunit ZNF326 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5BKZ1-3.


name: OSG1_CAEEL Rho guanine nucleotide exchange factor osg-1 (sprot)

description: A protein that is a translation product of the osg-1 gene in worm.


name: homeobox protein SIX3 isoform mSIX3B (mouse)

description: A homeobox protein SIX3 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q62233-1.


name: SIX3_MOUSE Homeobox protein SIX3 (sprot)

description: A homeobox protein SIX3 that is encoded in the genome of mouse.


name: homeobox protein SIX3 isoform mSIX3A (mouse)

description: A homeobox protein SIX3 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q62233-2.


diacylglycerol 35:2

A diglyceride in which the two acyl groups contain a total of 35 carbons and 2 double bonds.


name: protein phosphatase 1 regulatory subunit 3C isoform 1 (human)

description: A protein phosphatase 1 regulatory subunit 3C isoform 1 that is encoded in the genome of human.


name: protein-FAD linkage via S-(8alpha-FAD)-L-cysteine

description: The formation of a protein-FAD linkage via S-(8-alpha-FAD)-L-cysteine.


name: PUB36_ARATH U-box domain-containing protein 36 (sprot)

description: A protein that is a translation product of the PUB36 gene in Arabidopsis thaliana.


name: U-box domain-containing protein 36 isoform 1 (Arabidopsis thaliana)

description: A U-box domain-containing protein 36 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8GZ84-1.


name: electrogenic sodium bicarbonate cotransporter 1 isoform 1

description: An electrogenic sodium bicarbonate cotransporter 1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y6R1-1 or a 1:1 ortholog thereof.


name: electrogenic sodium bicarbonate cotransporter 1 isoform 1 (mouse)

description: An electrogenic sodium bicarbonate cotransporter 1 isoform 1 that is encoded in the genome of mouse.


name: electrogenic sodium bicarbonate cotransporter 1 isoform 1 (rat)

description: An electrogenic sodium bicarbonate cotransporter 1 isoform 1 that is encoded in the genome of rat.


name: electrogenic sodium bicarbonate cotransporter 1 isoform 1 (human)

description: An electrogenic sodium bicarbonate cotransporter 1 isoform 1 that is encoded in the genome of human.


Leu-Val-Ser

A tripeptide composed of L-leucine, L-valine and L-serine joined in sequence by peptide linkages.


(3R)-3-hydroxyacyl group

Any 3-hydroxyacyl group in which the carbon bearing the hydroxy substituent has R configuration.


(3R)-3-hydroxydecanoyl group

A (3R)-3-hydroxyacyl group derived from (3R)-3-hydroxydecanoic acid.


(3R)-3-hydroxypalmitoyl group

A (3R)-3-hydroxyacyl group derived from (3R)-3-hydroxypalmitoic acid.


butropium

A carboxylic ester resulting from the formal condensation of the carboxy group of (2S)-3-hydroxy-2-phenylpropanoic acid with the hydroxy group of (3-endo)-8-(4-butoxybenzyl)-3-hydroxy-8-methyl-8-azoniabicyclo[3.2.1]octane. Its bromide salt is used as an  antispasmodic drug.


name: 8-[2-[[5-[(4,5-dimethyl-1,2,4-triazol-3-yl)thio]-2-furanyl]methylidene]hydrazinyl]-8-oxooctanoic acid methyl ester


Recurrent Unspecified Lung Carcinoma

description: Lung carcinoma that has re-emerged after a period of remission.


Large cell lung cancer recurrent

description: The reemergence of large cell lung carcinoma after a period of remission.


name: Recurrent Lung Non-Small Cell Squamous Carcinoma

description: The reemergence of lung squamous non-small cell carcinoma after a period of remission.


Recurrent Bronchogenic Carcinoma

description: The reemergence of bronchogenic carcinoma after a period of remission.


name: Locally Recurrent Lung Non-Small Cell Carcinoma

description: The reemergence of lung non-small cell carcinoma after a period of remission, at or adjacent to the site of the original tumor.


Non-small cell lung cancer recurrent

description: The re-emergence of non-small cell lung carcinoma after a period of remission.


name: Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

description: The reemergence of non-squamous non-small cell lung carcinoma after a period of remission.


name: Adenosquamous cell lung cancer recurrent

description: The reemergence of adenosquamous lung carcinoma after a period of remission.


Lung adenocarcinoma recurrent

description: The re-emergence of lung adenocarcinoma after a period of remission.


Small cell lung cancer recurrent

description: The reemergence of small cell carcinoma of the lung after a period of remission.


Lung squamous cell carcinoma recurrent

description: The re-emergence of squamous cell lung carcinoma after a period of remission.


name: Recurrent Extensive Stage Lung Small Cell Carcinoma

description: Extensive stage small cell lung carcinoma that has reemerged after a period of remission.


protein TASOR 2 deaminated 2 (human)

A protein TASOR 2 (human) that has been deaminated on the residue at the position equivalent to Asn-2085 of the amino acid sequence represented by UniProtKB:Q5VWN6-1. Example: UniProtKB:Q5VWN6-1, Asn-2085, MOD:00684.


name: ETS domain-containing protein Elk-3 isoform Elk3a (mouse)

description: An ETS domain-containing protein Elk-3 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P41971-1.


name: CM2A1_DICDI Charged multivesicular body protein 2a homolog 1 (sprot)

description: A protein that is a translation product of the chmp2a1 gene in Dictyostelium discoideum.


An allotrope of carbon with molecular formula C18 existing as a ring of eighteen carbon atoms, connected by alternating triple and single bonds.


name: BAP2_YEAST Leu/Val/Ile amino-acid permease (sprot)

description: A protein that is a translation product of the BAP2 gene in yeast.


name: inhibin alpha chain isoform 1 cleaved and glycosylated form

description: An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue.


name: inhibin alpha chain, signal peptide removed form

description: An inhibin alpha chain that has had the signal peptide removed.


name: inhibin alpha chain isoform 1 cleaved 1 (human)

description: An inhibin alpha chain isoform 1 cleaved 1 in human. UniProtKB:P05111-1, 233-366.


name: inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)

description: An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160.


inhibin alpha chain isoform 1 cleaved 1

An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by subsequent removal of the propeptide, yielding the mature protein.